| 發表論文 | Publications
Articles
- Wu YY, Chang KP, Lin CY, Pai PC, Wang HM, Hsu CL, Liao CT, Yen TC, Fang TJ, Huang SF, Kang CJ, Fang KH, Lin WN, Wang YC, Hsin LJ, Tsang NM*. Prognostic significance of combined pretreatment lymphocyte counts and body mass index in patients with head and neck cancer treated with radiation therapy. Cancer Med. 2018 May 23. IF: 3.202 (111/223)
- Wu YY, Chang JT, Lin CY, Fan KH, Huang BS, Hung TM, Hsieh CE, Tsang NM*. Pretreatment lyphocyte count as prognositc factor in patients with head-and-neck cancer. Therapeutic Radiology and Oncology. Vol. 25, No 1, p.1-12, March 2018 (台灣放腫學會期刊)
- Yap WK, Chang YC, Tseng CK, Hsieh CH, Chao YK, Su PJ, Hou MM, Yang CK, Pai PC, Lin CR, Hsieh CE, Wu YY, Hung TM*. Predictive value of nodal maximum standardized uptake value of pretreatment [18F]fluorodeoxyglucose positron emission tomography imaging in patients with esophageal cancer. Dis Esophagus. 2017 Aug 1;30(8):1-10. IF: 2.702. (53/80)
Presentations
- Wu YY. Transoral Endoscopic Laser Microsurgery or Concurrent Chemoradiotherapy for T2N0 Larynx Cancer. The 58th annual meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO). 2016 Boston. USA (Poster)
- Wu YY. Transoral Endoscopic Laser Microsurgery or Concurrent Chemoradiotherapy for T2N0 Larynx Cancer. The 58th annual meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO). 2016 Boston. USA (Poster)
- Wu YY. Prognostic significance of combined lymphocyte counts and body mass index in head and neck cancer. The 37th annual meeting of the European Society for Radiotherapy and Oncology (ESTRO). 2018 Barcelona. Spain (Poster)
|
